CSPC Pharmaceutical Group Limited
CSPCY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $54 | $86 | $95 | $100 |
| - Cash | $7 | $12 | $12 | $9 |
| + Debt | $1 | $1 | $1 | $0 |
| Enterprise Value | $48 | $74 | $84 | $91 |
| Revenue | $31 | $35 | $35 | $34 |
| % Growth | -10.8% | -1.2% | 2.4% | – |
| Gross Profit | $22 | $24 | $23 | $25 |
| % Margin | 70% | 70.5% | 64.9% | 74.5% |
| EBITDA | $7 | $9 | $9 | $9 |
| % Margin | 22.2% | 24.7% | 24.7% | 27.1% |
| Net Income | $5 | $6 | $7 | $7 |
| % Margin | 14.9% | 17% | 19.7% | 20.1% |
| EPS Diluted | 1.56 | 2 | 2.04 | 1.88 |
| % Growth | -22% | -2% | 8.5% | – |
| Operating Cash Flow | $5 | $4 | $8 | $5 |
| Capital Expenditures | -$3 | -$2 | -$3 | -$2 |
| Free Cash Flow | $2 | $2 | $5 | $3 |